Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient

Transpl Infect Dis. 2018 Apr;20(2):e12843. doi: 10.1111/tid.12843. Epub 2018 Feb 12.

Abstract

Acanthamoeba infections are difficult to diagnose and treat. We present a renal transplant patient who developed Acanthamoeba endophthalmitis on therapy with posaconazole and miltefosine for cutaneous acanthamobiasis. The patient was maintained on intracameral voriconazole injections, and oral azithromycin, fluconazole, and flucytosine. This case highlights novel presentations and treatments for acanthamoebic infection.

Keywords: Acanthamoeba; amoebiasis; endophthalmitis; miltefosine; posaconazole.

Publication types

  • Case Reports

MeSH terms

  • Amebiasis / drug therapy*
  • Amebiasis / etiology
  • Amebicides / administration & dosage
  • Amebicides / therapeutic use*
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / therapeutic use
  • Endophthalmitis / drug therapy
  • Endophthalmitis / parasitology*
  • Endophthalmitis / pathology
  • Female
  • Humans
  • Immunocompromised Host
  • Kidney Transplantation*
  • Middle Aged
  • Skin Diseases, Parasitic / drug therapy*
  • Skin Diseases, Parasitic / etiology

Substances

  • Amebicides
  • Antifungal Agents